• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

RF ablation knocks out renal cell carcinoma

Article

Small tumors on the surface of the kidney can't escape from radio-frequency ablation treatment, according to researchers at Massachusetts General Hospital.

Small tumors on the surface of the kidney can't escape from radio-frequency ablation treatment, according to researchers at Massachusetts General Hospital.

In the largest such study to date, the group followed 34 patients who had been treated with RF ablation for 42 renal cell carcinoma tumors during a 3.5-year period. They were able to completely ablate all of the 29 exophytic tumors and both parenchymal tumors in one or more visits. The mean diameter of the tumors was 3.2 cm. The team could completely ablate only five of the 11 tumors that had a component in the renal sinus, which acts as a heat sink by continuously allowing cool blood to flow into the area. The study was published in the February issue of Radiology.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.